Company Overview

Veeva Systems Inc. is a publicly traded enterprise software company that provides cloud-based solutions primarily to the life sciences industry, including pharmaceutical, biotechnology, and medical device companies. The company operates at the intersection of software-as-a-service (SaaS) and regulated healthcare markets, focusing on helping customers manage commercial operations, clinical development, regulatory compliance, and quality processes. Veeva’s offerings are designed to address industry-specific requirements such as data integrity, regulatory compliance, and global scalability.

The company’s primary revenue drivers are its subscription-based software platforms and related services, with a strong emphasis on long-term customer relationships and recurring revenue. Veeva is widely recognized for its deep industry specialization and its strategic partnership with Salesforce, which underpins several of its core products. Founded in 2007, Veeva initially focused on customer relationship management for life sciences sales teams and has since expanded into clinical, regulatory, quality, and data management, evolving into a broad enterprise platform for regulated industries.

Business Operations

Veeva operates through two primary business segments: Veeva Commercial Solutions and Veeva R&D Solutions. Veeva Commercial Solutions includes CRM, data, and analytics products that support sales, marketing, medical affairs, and customer engagement functions for life sciences companies. Veeva R&D Solutions focuses on cloud applications for clinical development, regulatory submissions, quality management, and safety, enabling customers to manage the end-to-end drug and device development lifecycle.

The company generates revenue primarily through subscription fees, with a smaller portion derived from professional services such as implementation and training. Veeva operates globally, serving customers across North America, Europe, and Asia-Pacific, and controls proprietary cloud platforms including Veeva Vault, which is used for content and data management in regulated environments. The company maintains strategic technology relationships, most notably its long-standing platform relationship with Salesforce, and operates through wholly owned subsidiaries rather than large-scale joint ventures.

Strategic Position & Investments

Veeva’s strategic direction centers on expanding its platform approach within life sciences while extending select solutions into adjacent regulated industries. Growth initiatives include broadening the capabilities of Veeva Vault, increasing adoption of its clinical and quality applications, and expanding data and analytics offerings that support real-time decision-making. The company emphasizes organic development over large acquisitions, investing heavily in research and development to enhance product depth and regulatory alignment.

Notable strategic investments include continued platform independence initiatives, such as the development of Veeva Vault CRM to reduce reliance on third-party infrastructure over time. Veeva does not operate as a holding company with a broad investment portfolio; instead, it focuses on scaling its core software platforms and selectively acquiring smaller technologies when aligned with its long-term product roadmap. Its strategic positioning is reinforced by high switching costs, regulatory expertise, and deep integration into customer workflows.

Geographic Footprint

Veeva Systems is headquartered in North America, with its principal executive offices in Pleasanton, California. The company has a significant market presence in the United States, which represents its largest revenue base, while also maintaining strong operations across Europe and Asia-Pacific. Its international footprint supports global pharmaceutical and biotechnology customers operating in multiple regulatory jurisdictions.

The company maintains offices and operational teams in key markets including Western Europe, Japan, and China, reflecting its focus on multinational life sciences organizations. Veeva’s software platforms are used globally, giving the company international operational influence despite a relatively centralized corporate structure. International revenue represents a substantial portion of total revenue, underscoring its global customer base.

Leadership & Governance

Veeva was founded by Peter Gassner, who continues to play a central role in shaping the company’s long-term strategy and culture. The leadership team emphasizes customer-centric innovation, long-term value creation, and operational discipline, with a governance philosophy that prioritizes sustainable growth and independence. Veeva is known for a mission-driven approach that stresses product quality, regulatory trust, and employee engagement.

Key executives include:

• Peter Gassner – Founder and Chief Executive Officer
• Paul Shawah – Executive Vice President, Strategy
• Matt Wallach – President
• Brian Van Wyk – Chief Financial Officer
• Andy Graham – Chief Customer Officer

The board and executive leadership maintain a long-term strategic vision focused on deepening industry specialization and expanding Veeva’s role as a core infrastructure provider to regulated life sciences organizations.